EKB Journal Management System
Keywords = Ribavirin
Number of Articles: 34

1

Study of the effects of Sofosbuvir based treatments on liver stiffness in chronic Hepatitis C patients using transient Elastography

Volume 30, Issue 4, July and August 2024, Page 1090-1097
Osama Mohamed Basha; Mahmoud Al Gharieb Abd ELBari; Ahmed Awad Bessar; Amr Shaban Hanafy

2

Potential antiviral activity of metformin against human Adenovirus-7

Volume 5, Issue 2, May 2024, Page 571-580
Ibrahim Ashraf Abdelwahab; Gihan Adel ELBatouti

3

The Histopathological Effect of Sofosbuvir as Compared to Sofosbuvir Combined with Ribavirin on Submandibular Salivary Glands of Adult Albino Rats (Histological and Immunofluorescent Study)

Volume 46, Issue 3, September 2023, Page 1262-1271
Alaa Ossama Shawkat; Zoba H Ali; maha bashir

4

Serum markers in monitoring the outcome of Sofosbuvir-based treatments in HCV genotype 4 Egyptian patients

Volume 60, Issue 1, January 2022, Page 73-84
Hiam Salem; Nadia Y. S. Morcos; Wahid Doss; Mohamed Makhlouf; Kamal El Atrebi; Eman Saleh

5

Association of ITPA Gene Expression and Hematological Abnormalities Induced by Dual therapy in HCV-infected Patients

Volume 11, Issue 1, September 2021, Page 56-66
Naglaa ELarabany; Nahed A. Omar; Mostafa M. Elshaer; Ahmed Abdelkhalek; Mai Alaa Eldin Ali Rashed

6

Assessment of Patient Compliance during treatment of chronic hepatitis C infection using Sofosbuvir and Daclatasvir with or without Ribavirin.

Volume 5.2, Issue 2, March 2021, Page 32-39
Sarah Ali; Farag Mohamed; Maha R Habeeb

7

Outcome of Decompensated Hepatitis C Virus Cirrhotic Patients Treated with Direct Acting Antiviral Drugs

Volume 27, Issue 1, January 2021, Page 70-80
Amir Ahmed; Sahar Gouda Zagloul; Hoda Abdel-aziz El-hady; Ahmed Fathy Gomaa

8

Studying the Kynurenine, Some Hematological and Biochemical Changes on Egyptian Patients with Chronic Hepatitis C During and After Treatment with Sofosbuvir

Volume 5, Issue 7 part (1) - (2), October 2020, Page 291-301
N. H. Abdel_Hameid; L.Y. Mousa; E.M. Shaheen; F. S. Ibrahim

9

Evaluation of the Role of the Silymarin in Modulating the Cytotoxicity of Sofosbuvir and Ribavirin as Antiviral Drugs in Mice Bone Marrow and Sperm

Volume 5, Issue 6 part (1), September 2020, Page 133-139
M.E. Zowail; N.A. El kamshishy; E.H. Khater

10

Efficacy of Sofosbuvir-Daclatasvir in Treatment of Chronic Hepatitis C Virus Infection

Volume 5, Issue 6 part (2), September 2020, Page 241-251
Y.S. Younis; T.E. Elazab; E.M. Abd El-Fattah

11

MOLECULAR MARKERS PREDICTING THE EFFICACY OF INTERFERON-BASED THERAPIES IN PATIENTS WITH CHRONIC HEPATITIS C

Volume 35, Issue 1, January and February 2020, Page 1-16

12

Retinal Changes In Patients with Hepatitis C Virus under treatment with interferon and ribavirin.

Volume 1, Issue 1, January 2020, Page 107-121
Mansour Hassan Ahmad Hassan; Mohamed Osman; Waleed El-Nabawy; Alzahraa Yasseen Sayed

13

Evaluation of Sofosbuvir plus Ribavirinin Treatment of Cirrhotic Hepatitis C Patients: An Egyptian Study

Volume 28, Issue 1, January 2019, Page 15-22
Alaa Aboud; Mostafa S. ABDEL-MOTaleb; Ehab M. Fahmy

14

Efficacy and Adverse Effects of Sofosbuvir plus Daclatasvir Therapy in Chronic HCV Patients in Sharkia Governorate, Egypt

Volume 8, Issue 4, December 2018, Page 174-181
Nahla E El-Gammal; Noha E Shahin; Abeer Hussein abdelkader

15

Comparison between the effect of Two Regimens for Hepatitis C Treatment (Qurevo and Ribavirin) and (Sofosbuvir, Daclatsvir and Ribavirin) on Patients above and below the Age of 60 Years

Volume 72, Issue 10, July 2018, Page 5385-5390
Mahmoud Abd El Majeed Othman; Motaz Mohamed Saied Abd EL Mawjood; Mohamed Osama Aly Aly; Aya Ahmed Morsy El Ghamry

16

EFFICACY OF SOFOSBUVIR, DACLAVIR AND RIBAVIRIN IN TREATMENT OF HCV INFECTION WITH DIFFERENT STAGES OF LIVER DISEASE

Volume 47, Issue 2, April 2018, Page 305-320
Magdy A. ELDahshan; Fathy E. Abdel Razik; Hala M Abdel-Mageed; Ayman R. Abd El-Kader; Tarek Refaat; Hassan Ahmed Hassan Ghareeb

17

THE USE OF DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN IN TREATMENT-NAÏVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 4 INFECTION

Volume 68, Issue 68, December 2017, Page 239-254
N. Elarabany; Hend M. Solyman; Tarek A. Besheer; Gamal A. Abd-Allah

18

EFFECTS OF SOFOSBUVIR AND RIBAVIRIN ON SOME HAEMATOLOGICAL AND BIOCHEMICAL PARAMETERS IN NORMAL RATS

Volume 68, Issue 68, December 2017, Page 181-196
N. F. Elarabany; S. A. Eltamtame; K. A. Elbakry; G. A. Abdallah

19

Chronic Hepatitis C Treatment: A Systematic Review

Volume 67, Issue 1, April 2017, Page 305-313
Aishah Mohammed Alenezi; Abdulaziz Hassan Mohammed Al-Fakih; Sultan Mohammed Al-Afif; Abdulkarem Mohammed Al-Afif; Bashayer Abbas Habib

20

Pegylated Interferon, Ribavirin, and Sofosbuvir Combination versus Pegylated Interferon, Ribavirin in the Management of Chronic Hepatitis C Egyptian Patients

Volume 1, Issue 1, January 2017, Page 25-33
Abdel-Hameed Ebid; Mohamed Mobarez; Mohamed Adel; Ramadan Ramadan

21

IMPACT OF INSULIN RESISTANCE AND SERUM ZINC ON RESPONSE TO PEG-INTERFERON/RIBAVIRIN COMBINATION THERAPY IN NON-DIABETIC PATIENTS WITH CHRONIC HEPATITIS C

Volume 46, Issue 1, January 2017, Page 45-56
Adel Ahmed Soliman Al-Sahhar; Alsayed Almaghawry Alsayed; Hassan Abdel-Hafiez Rashed; Ali Ebraheim Ali Soliman; Mahmoud Bastawy Ismael; Mohammad Fawzy Abdel-Gaber

22

Histological Study on the Effects of Sofosbuvir and/or Ribavirin on Normal Rats

Volume 6, Issue 2, December 2016, Page 144-149
Gamal A. Abdallah; Kadry A. Elbakry; Naglaa F. Elarabany; Seeg A. Altamtam

23

Sofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience

Volume 2.1, Issue 1, November 2016, Page 1-8
Shiha G.; El-Basiouny M.; Soliman R.; Mikhail NNH.

24

Impact Of An Eductional Program On: Knowledge And Practice Of Hepatitis C Infected Patients Treated By Pegylated Interferon And Ribavirin.

Volume 3, Issue 1, June 2016, Page 190-211
Shaimaa Abdo Rizq

25

Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients

Volume 6, Issue 2, June 2016, Page 94-102
Mohamed H Khater; Fathia M Khattab; Mohamed M Refaey

First Page Previous Page 1 2 Next Page Last Page